Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Ian Shott provides foreword to the ‘Engineering Biology: A Priority for Growth’ report

Our “Individuals, groups and communities working in engineering biology must get together at this important time and agree how they can build better connections and incentivise this collaboration to deliver more economic and societal impact.”

Our Executive Chairman, Ian Shott, discusses the potential for engineering biology to deliver economic and social benefits to the UK in the Royal Academy of Engineering’s ‘Engineering Biology: A Priority for Growth’ report. His foreword explores the need for urgent action to build upon the rapid progress in synthetic biology achieved in the last decade and accelerate commercialisation of emerging technologies. By supporting greater collaboration between different disciplines and industries, the UK can ensure that it is an international leader in engineering biology.

Read the report here

Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.